GRIN2B and Parkinson disease: The LPS-treated PD rats showed significantly higher levels of phosphorylation of NR2B and total NR2B, in response to L-dopa, compared with the PD+saline+L-dopa group (*p < 0.05 vs. PD + saline+ L-dopa, Figures 4A,B, n = 4/group).